DOVER Corp
No SEC Form 4 filings for $DOV in the last 30 days.
See all $DOV insider activity →Argus on Aug 12, 2026 lowered its price target for Dover Corporation (DOV) to $229.00. The piece is presented as a stock forecast update and does not include additional operating or financial details.
Dover announced it has closed its acquisition of Cloeren. The article also notes that Morgan Stanley adjusted its price target on Dover to $215 from $230 while keeping an Equalweight rating. Dover shares were shown at $208.07, down 0.18% on the day.
Dover Corporation (NYSE: DOV) said it has completed its previously announced acquisition of Cloeren Incorporated. Cloeren will be integrated into Dover’s MAAG business unit within the Pumps and Process Solutions segment. The company did not provide new financial terms in the release.
Over the past 7 days, alphai's AI scored 4 news stories mentioning DOV (DOVER Corp). Coverage has been balanced: 1 bullish, 2 neutral, and 1 bearish.
Recent DOV coverage spans mergers & acquisitions, financial news and corporate actions.
A target-price cut typically pressures near-term sentiment and can widen valuation discount expectations, though it is not a fundamental earnings or guidance change by itself.
Deal closure typically reduces headline deal risk and can shift focus to integration execution and any remaining regulatory or financing steps.
Deal completion is a concrete corporate milestone, but the release provides no new financial terms or guidance beyond integration structure.
The dividend hike is small but reinforces capital-return durability, with the main risk being slower industrial demand that could slow future increases.
The note implies modestly less upside versus the prior target, but the unchanged Equalweight rating suggests no major thesis shift.
alphai scores every news story that mentions DOV with an AI model for sentiment and relevance, and aggregates insider trades from DOVER Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Argus on Aug 12, 2026 lowered its price target for Dover Corporation (DOV) to $229.00. The piece is presented as a stock forecast update and does not include additional operating or financial details.
2 min readDover announced it has closed its acquisition of Cloeren. The article also notes that Morgan Stanley adjusted its price target on Dover to $215 from $230 while keeping an Equalweight rating. Dover shares were shown at $208.07, down 0.18% on the day.
1 min readDover Corporation (NYSE: DOV) said it has completed its previously announced acquisition of Cloeren Incorporated. Cloeren will be integrated into Dover’s MAAG business unit within the Pumps and Process Solutions segment. The company did not provide new financial terms in the release.
2 min readDover Corp. (NYSE:DOV) raised its quarterly cash dividend to $0.525 per share from $0.52 on Aug. 10, marking 71 straight years of annual increases. The article cites 2025 free cash flow of about $1.1 billion (13.8% of revenue) and adjusted EPS of $9.61, plus Q1 2026 free cash flow rising to over $188 million from $131 million.
5 min readMorgan Stanley adjusted its price target on Dover Corp to $215 from $230 and kept an Equalweight rating, according to the brokerage. The article provides Dover’s business segment mix and geographic revenue distribution but no other financial figures.
2 min readDover Corporation (NYSE:DOV) said its board raised the quarterly dividend to $0.525 per share from $0.52, a $0.005 increase. The payment is scheduled for Sept. 15, 2026, to shareholders of record Aug. 31, 2026. Dover cited 71 consecutive years of dividend increases and reported revenue above $8 billion.
2 min readDover Corporation (NYSE: DOV) said its board increased the quarterly cash dividend to $0.525 per share from $0.52. The payment is scheduled for Sept. 15, 2026, to shareholders of record as of Aug. 31, 2026. Dover cited this as its 71st consecutive annual dividend increase.
1 min readJim Cramer’s Charitable Trust plans to sell 90 shares of Dover (DOV) around $204, cutting its DOV weighting to 1% from about 1.5%. It will buy 60 shares of Johnson & Johnson (JNJ) around $253, raising JNJ weighting to about 2.55%. The article also says the trust is eyeing Intel (INTC) and Corning (GLW).
4 min readAccording to Linklaters, Dover Corporation has signed a definitive agreement to acquire Cloeren Incorporated. The report says Linklaters advised Dover on the transaction. The deal’s impact for investors depends on deal terms, timing, and regulatory approvals.
1 min readDover (according to the company) signed an agreement to acquire Cloeren, a maker of extrusion T-dies and feedblocks for polymer and plastics processing. Terms were not disclosed. The deal is expected to close in Q3 2026, subject to conditions, and Cloeren will join Dover’s MAAG unit in the Pumps and Process Solutions segment. Dover has $8B+ annual revenue.
4 min read
